cyclacillin has been researched along with erythromycin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Deguchi, K | 1 |
3 other study(ies) available for cyclacillin and erythromycin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[In vitro examination on antibacterial activity of ciclacillin (ACPC) against clinically isolated strains (author's transl)].
Topics: Amoxicillin; Cephalexin; Cyclacillin; Erythromycin; Escherichia coli; Leucomycins; Penicillin Resistance; Penicillins; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes | 1977 |